Plaque Excision in the Treatment of Peripheral Arterial Disease

Abstract

The goals of any percutaneous intervention in the lower extremity are to provide initial technical success and restore durable arterial patency. The first goal can be achieved through a multitude of endovascular techniques, whereas achieving the latter has remained elusive. The large number of choices in treatment options for percutaneous lower-extremity revascularization speak to the fact that no single tool or technique has been proven to be superior. The SilverHawk plaque excision system is designed to debulk stenotic or occlusive arterial lesions. Like many endovascular technologies, reports have focused on rates of initial technical success and short-term outcomes, but long-term results remain unknown. This report reviews selected published or presented results of plaque excision, touches on areas of concern or controversy regarding both the device and some of its proponents, and suggests clinical or anatomic settings in which plaque excision appears most effective. The ultimate utility of this technology will depend on confirmation of its acute and long-term outcomes through unbiased, well-designed clinical trials.

Keywords

percutaneous revascularization SilverHawk occlusive arterial lesions peripheral vascular disease

Get full access to this article

View all access options for this article.

References

1. Wensing PJ , Scholten FG , Buijs PC et al. Arterial tortuosity in the femoralpopliteal region during knee flexion: a magnetic resonance angiographic study. J Anat 187:133-139, 1995.

2. Diaz JA , Villegas M , Tamashiro G , et al. Flexions of the popliteal artery: dynamic angiography. J Invas Cardiol 16:712-712, 2004.

3. Scheinert D , Scheinert S , Sax J , et al. Prevalence and impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45:312-315, 2005.

4. Arena FJ . Arterial kink and damage in normal segments of the superficial femoral and popliteal arteries abutting nitinol stents-a common cause of late occlusion and restenosis? A single-center experience. J Invas Cardiol 17:482-486, 2005.

5. Dorros G , Iyer S , Lewin R , et al. Angiographic follow-up and clinical outcome of 126 patients after percutaneous directional atherectomy (Simpson AtheroCath) for occlusive peripheral vascular disease. Cathet Cardiovasc Diagn 22:79-84, 1991.

6. Zeller T , Rastan A , Schwarzwalder U , et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses usinf a new-generation device: six-month results from a single-center experience. J Endovasc Ther 11:676-685, 2004.

7. Zeller T , Rastan A , Schwarzwalder U , et al. Midterm results after atherectomy-assisted angioplasty of below-knee arteries with use of the Silverhawk device. J Vasc Interv Radiol 15:1391-1397, 2004.

8. Okhi T . SFA disease: Facing reality. Endovasc Today 4:47-48, 2005.

9. Allie DE , Hebert CJ , Lirtzman MD , et al. Plaque excision in “real world” superficial femoral artery disease: 12-month clinical and angiographic follow-up. Presented at TCT, October 2005, Washington, DC.

10.

10. Ramaiah V . SilverHawk plaque excision: one-year revascularization outcomes for femoropopliteal lesions. Presented at TCT, October 2005, Washington D.C.

11.

11. Gammon R . Plaque excision treatment of infrainguinal PAD. Endovasc Today 4:70-74, 2005.

12.

12. Gammon R , Cardenas J , Ramaiah V , et al. Acute and Long-term outcomes for treatment of lower extremity PAD with SilverHawk plaque excision system. Presented at TCT, October 2005, Washington DC.

13.

13. McKinsey JF , Ramaiah VG , Runyon JP , et al. 1 year results of treatment of infrapopliteal arterial occlusive disease using the Silverhawk plaque excision device. Jan 2005. http://www.pvss.org/abstracts/wabsO6/wO505.pdf

14.

14. Kandzari DE , Kiesz RS , Allie D , et al. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther 2006; 13:12-22.

15.

15. Wholey MH , Suri R , Postoak D , et al. Plaque excision in 2005 and beyond: Issues of the past have yet to be resolved. Endovasc Today 4:40-45, 2005.